Position in BRKR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,156,291
-$11,842,805 QoQ
Shares Held
59,698
-86.1% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BRKR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NATIXIS holds $149,303,624 across 13 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
144,712 | $45,561,126 | |
| 2 | PEN |
Penumbra Inc
|
124,458 | $39,297,613 | |
| 3 | ABT |
Abbott Laboratories
|
185,746 | $16,854,592 | |
| 4 | EW |
Edwards Lifesciences Corp
|
183,344 | $16,585,298 | |
| 5 | PODD |
Insulet Corp
|
79,197 | $12,057,743 | |
| 6 | BSX |
Boston Scientific Corp
|
168,036 | $7,171,776 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
67,365 | $4,312,033 | |
| 8 | AHCO |
AdaptHealth Corp.
|
350,000 | $3,647,000 |
All Filings in BRKR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,156,291 | 59,698 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $13,999,096 | 430,874 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,926,518 | 71,032 | Shares | Sole | 2025-08-13 | |
| 2024-06-30 | $20,036 | 314 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $109,064 | 1,161 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $122,197 | 1,663 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,516,008 | 24,334 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $98,904 | 1,338 | Shares | Sole | 2023-08-11 | |
| 2022-03-31 | $320,857 | 4,990 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $291,503 | 3,474 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,018,159 | 64,253 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||